DANBURY, Conn., Nov. 5, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today reported its financial results for the third quarter of 2009. Compared with the third quarter of 2008, revenues more than quadrupled, and operating expenses decreased by 32%. The Company also achieved its first quarterly net profit.
